Enanta Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
January 06 2014 - 8:30AM
Business Wire
Presentation to be Webcast on January 14,
2014 at 11:00 A.M. PT
Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and
development-focused biotechnology company dedicated to creating
small molecule drugs in the infectious disease field, today
announced that Jay R. Luly, Ph.D., President and Chief Executive
Officer, will make a presentation regarding the company on January
14, 2014, at 11:00 A.M. PT during the 32nd Annual J.P. Morgan
Healthcare Conference in San Francisco. A question and answer
session with investors will follow the presentation.
The presentation and the question and answer session will be
webcast live and can be accessed by visiting the Investor homepage
section of Enanta’s website at www.enanta.com. A replay of the
presentation and question and answer session will be available
following the sessions and will be archived for approximately 60
days.
About Enanta
Enanta Pharmaceuticals is a research and development-focused
biotechnology company that uses its robust chemistry-driven
approach and drug discovery capabilities to create small molecule
drugs in the infectious disease field. Enanta is discovering, and
in some cases developing, novel inhibitors designed for use against
the hepatitis C virus (HCV). These inhibitors include members of
the direct acting antiviral (DAA) inhibitor classes – protease
(partnered with AbbVie), NS5A (partnered with Novartis) and
nucleotide polymerase – as well as a host-targeted antiviral (HTA)
inhibitor class targeted against cyclophilin. Additionally, Enanta
has created a new class of antibiotics, called Bicyclolides, for
the treatment of multi-drug resistant bacteria, with a focus on
developing an intravenous and oral treatment for hospital and
community MRSA (methicillin-resistant Staphylococcus aureus)
infections.
Enanta Pharmaceuticals, Inc.Carol Miceli,
617-607-0710cmiceli@enanta.com
Enanta Pharmaceuticals (NASDAQ:ENTA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enanta Pharmaceuticals (NASDAQ:ENTA)
Historical Stock Chart
From Jul 2023 to Jul 2024